Zydus Life
A global lifesciences company driven by the purpose of delivering care and nurturance for the patients, backed by the power of innovation, science and cutting edge technology. With these attributes close to our heart, we wish to make a meaningful difference in …
About Zydus Group - The Leading Indian Pharma Company
Driven by creativity and innovation, we strive for excellence and to make a difference in the world of pharmaceuticals and healthcare. Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited), a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider.
Zydus Lifesciences - Wikipedia
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, [3] is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. [4] [5] [6] The company ranked 100th in the Fortune India 500 list in 2020. [7]
ALS treatment: Zydus receives USFDA Orphan Drug Designation …
1 day ago · Zydus Lifesciences announced that the USFDA granted Orphan Drug Designation to Usnoflast, a novel oral NLRP3 inhibitor, for treating amyotrophic lateral sclerosis (ALS), a rare fatal neurodegenerative disease. Clinical trials indicate promising results, and further trials are planned. ALS affects over 30,000 people in the US annually.
Zydus Lifesciences' Usnoflast Gets FDA's Orphan Drug Status
1 day ago · Zydus Lifesciences Ltd. said on Wednesday that the US Food and Drug Administration granted its underdevelopment drug Usnoflast the orphan drug designation, according to an exchange filing on Wednesday. The FDA's Office of Orphan Drug Products grants orphan status to support the development of medicines for the treatment of rare diseases that …
Zydus Pharmaceuticals
Zydus Lifesciences is a global, fully integrated pharmaceutical company with a presence in 50 countries and is committed to growing its presence around the world and in the United States. Zydus products were developed to save and improve patients’ lives.
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
4 days ago · Zydus Lifesciences chairman Pankaj Patel said: “We are excited to report the approval from the USFDA to initiate this randomised, double-blind, placebo-controlled Phase IIb clinical trial in ALS ...
Zydus Lifesciences Receives Approval from USFDA to Conduct …
6 days ago · Zydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations.
Zydus Life up 2% on USFDA nod for Phase II(b) clinical trial for ...
4 days ago · Zydus Lifesciences Ltd, previously known as Cadila Healthcare Ltd, is a global company in the life sciences sector. It focuses on discovering, developing, manufacturing, and marketing healthcare therapies. The company’s portfolio includes a range of products: finished dosage human formulations (such as generics, branded generics, specialty ...
Building on a rich legacy of over 70 years in healthcare, the group is today one of the leading, innovation-driven, global lifesciences companies.